Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | PPIA | P62937 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8678097 | 0.93 | GAA (0.54) | ALDH1A1MAPK1SIGMAR1POLBGAA | |
| SCHEMBL5861427 | 0.91 | POLB (0.49) | ALDH1A1MAPK1SIGMAR1POLBGAA | |
| SCHEMBL1476176 | 0.89 | SLC6A2 (0.48) | ALDH1A1MAPK1SIGMAR1POLBGAA | |
| Hydrochloric Acid SCHEMBL1474677 | 0.87 | SLC6A2 (0.47) | ALDH1A1MAPK1SIGMAR1POLBGAA | |
| SCHEMBL1473936 | 0.81 | SIGMAR1 (0.70) | ALDH1A1SIGMAR1KMT2A | |
| SCHEMBL1475345 | 0.80 | POLB (0.43) | ALDH1A1MAPK1SIGMAR1POLBGAA | |
| SCHEMBL3761179 | 0.79 | CTBP2 (0.50) | ALDH1A1MAPK1SIGMAR1LMNARAB9A | |
| SCHEMBL1474642 | 0.79 | ALDH1A1 (0.41) | ALDH1A1MAPK1SIGMAR1POLBGAA | |
| SCHEMBL12827509 | 0.79 | ALDH1A1 (0.41) | ALDH1A1MAPK1SIGMAR1POLBGAA | |
| SCHEMBL1474639 | 0.79 | ALDH1A1 (0.41) | ALDH1A1MAPK1SIGMAR1POLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 180 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109311907-B | Preparation method of high-purity prasugrel | 吉瑞工厂 | 2022-09-13 | — | — | CN | claimed |
| EP-3475288-B1 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | RICHTER GEDEON NYRT (HU) | 2021-11-03 | — | — | EP | claimed |
| US-20190211029-A1 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | RICHTER GEDEON NYRT. (HU) | 2019-07-11 | — | — | US | claimed |
| EP-3475288-A1 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | Richter Gedeon Nyrt. (HU) | 2019-05-01 | — | — | EP | claimed |
| WO-2017221187-A1 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | RICHTER GEDEON NYRT. (HU) | 2017-12-28 | — | — | WO | claimed |
| EP-2471795-B1 | METHOD FOR PREPARING PRASUGREL | ZHEJIANG HUAHAI PHARM CO LTD (CN) | 2016-04-20 | — | — | EP | claimed |
| WO-2014114964-A2 | IMPROVED PROCESS FOR THE PREPARATION OF PRASUGREL AND INTERMEDIATE THEREOF | EGIS PHARMACEUTICALS PUBLIC LIMITED COMPANY (HU) | 2014-07-31 | — | — | WO | claimed |
| US-20140142311-A1 | METHOD FOR PREPARING PRASUGREL | ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) | 2014-05-22 | — | — | US | claimed |
| US-20130274284-A1 | PREPARATION OF PRASUGREL HYDROCHLORIDE | DR. REDDY'S LABORATORIES, INC. (US) | 2013-10-17 | — | — | US | claimed |
| EP-2545059-A1 | A PROCESS FOR MAKING PRASUGREL | Synthon BV (NL) | 2013-01-16 | — | — | EP | claimed |
| US-20120202066-A1 | Processes For Preparing Prasugrel And Pharmaceutically Acceptable Salts Thereof | MSN LABORATORIES LIMITED (IN) | 2012-08-09 | — | — | US | claimed |
| EP-2471795-A1 | METHOD FOR PREPARING PRASUGREL | Zhejiang Huahai Pharmaceutical Co., Ltd. (CN) | 2012-07-04 | — | — | EP | claimed |
| US-20120142927-A1 | METHOD FOR PREPARING PRASUGREL | ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) | 2012-06-07 | — | — | US | claimed |
| US-8193358-B2 | Process for producing high-purity prasugrel and acid addition salt thereof | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-06-05 | — | — | US | claimed |
| WO-2012052788-A1 | METHOD FOR PREPARING PHARMACEUTICALLY ACTIVE INGREDIENT AND INTERMEDIATES THEREOF | EGIS GYÓGYSZERGYÁR NYILVÁNOSAN MŰKÖDŐ RÉSZVÉNYTÁRSASÁG (HU) | 2012-04-26 | — | — | WO | claimed |
| WO-2012001486-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF PRASUGREL HYDROCHLORIDE AND ITS INTERMEDIATES | MAYUKA LABS PVT. LTD. (IN) | 2012-01-05 | — | — | WO | claimed |
| WO-2011110219-A1 | A PROCESS FOR MAKING PRASUGREL | SYNTHON BV (NL) | 2011-09-15 | — | — | WO | claimed |
| CN-102140059-A | Method for preparing 1-cyclopropyl-3-(2-fluorobenzyl) ketone | CHENGDU KANGHONG PHARMACEUTICALS GROUP CO LTD | 2011-08-03 | — | — | CN | claimed |
| WO-2011042918-A2 | NOVEL AND IMPROVED PROCESSES FOR THE PREPARATION OF PRASUGREL, ITS INTERMEDIATES AND PHARMACEUTICALLY ACCEPTABLE SALTS | MSN LABORATORIES LIMITED (IN) | 2011-04-14 | — | — | WO | claimed |
| WO-2009066326-A2 | IMPROVED PROCESS FOR THE PREPARATION OF PRASUGREL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS | MSN LABORATORIES LIMITED (IN) | 2009-05-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130274284-A1 | PREPARATION OF PRASUGREL HYDROCHLORIDE | PFKP, PF4, PTAFR | ALDH1A1 1209/4885MAPK1 2119/4885SIGMAR1 4021/4885 |
| US-20120142927-A1 | METHOD FOR PREPARING PRASUGREL | FDPS, PFAS, PF4 | ALDH1A1 536/4885MAPK1 2781/4885SIGMAR1 3753/4885 |
| US-20190211029-A1 | PROCESS FOR THE PREPARATION OF HIGH-PURITY PRASUGREL | CYP3A5, CYP4B1, AGPS | ALDH1A1 946/4885MAPK1 1242/4885SIGMAR1 3587/4885 |
| US-20140142311-A1 | METHOD FOR PREPARING PRASUGREL | PFAS, FDPS, PF4 | ALDH1A1 475/4885MAPK1 2745/4885SIGMAR1 3928/4885 |
| US-20120202066-A1 | Processes For Preparing Prasugrel And Pharmaceutically Acceptable Salts Thereof | SF1, PFKP, CYP2F1 | ALDH1A1 340/4885MAPK1 507/4885SIGMAR1 2352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.